MENU
+Compare
CTSO
Stock ticker: NASDAQ
AS OF
Apr 4, 11:50 AM (EDT)
Price
$0.95
Change
-$0.04 (-4.04%)
Capitalization
49.22M

CTSO Cytosorbents Corp Forecast, Technical & Fundamental Analysis

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology... Show more

CTSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CTSO with price predictions
Apr 03, 2025

CTSO's Stochastic Oscillator remains in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTSO advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CTSO as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CTSO turned negative on March 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

CTSO moved below its 50-day moving average on March 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CTSO crossed bearishly below the 50-day moving average on March 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CTSO entered a downward trend on March 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.115) is normal, around the industry mean (23.715). P/E Ratio (0.000) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.302) is also within normal values, averaging (41.612).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTSO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
CTSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CTSO is expected to report earnings to rise 116.67% to -6 cents per share on May 06

Cytosorbents Corp CTSO Stock Earnings Reports
Q1'25
Est.
$-0.06
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.01
The last earnings report on March 31 showed earnings per share of -2 cents, beating the estimate of -5 cents. With 10.46K shares outstanding, the current market capitalization sits at 49.22M.
A.I. Advisor
published General Information

General Information

a developer of products to support healthcare professionals in the treatment of complex medical conditions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
305 College Road East
Phone
+1 732 329-8885
Employees
186
Web
https://www.cytosorbents.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTZ14.290.26
+1.85%
Utz Brands
ICE167.56-2.88
-1.69%
Intercontinental Exchange
TX29.69-1.59
-5.08%
Ternium SA
ATNM1.39-0.13
-8.55%
Actinium Pharmaceuticals
FRGE0.51-0.08
-14.07%
Forge Global Holdings

CTSO and Stocks

Correlation & Price change

A.I.dvisor tells us that CTSO and LUNG have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTSO and LUNG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTSO
1D Price
Change %
CTSO100%
-1.00%
LUNG - CTSO
25%
Poorly correlated
-0.88%
NNOX - CTSO
25%
Poorly correlated
-4.89%
RBOT - CTSO
24%
Poorly correlated
-4.60%
CORBF - CTSO
24%
Poorly correlated
N/A
AZTA - CTSO
23%
Poorly correlated
-11.61%
More